Search, preview, and bulk-unlock all verified HTTP 402 & Nano P2P telemetry datasets matching nct06215287 across With Silex's 48 real-time subdomains.
MATCHING PAYWALLS
1 (1 in Pack)
WHOLE-PACK BULK PRICE
$0.005 USD in XNO
CONTRIBUTING SUBDOMAINS
clinical-trials.withsilex.com
LATEST VERIFIED UTC
2026-11-20 13:30 UTC
🆓 Free Public Citation & Sample Record #1 (clinical-trials.withsilex.com)
Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension
{
"nct_id": "NCT07650084",
"title": "A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension",
"status": "TERMINATED",
"phase": "PHASE3",
"conditions": "Refractory Chronic Cough",
"verify_url": "https://clinicaltrials.gov/study/NCT07650084"
}
🔓 UNLOCKED WHOLE KEYWORD LIBRARY (1 DATASETS)
{"id":"pulse_clinical-trials_20261120-1330","url":"https://clinical-trials.withsilex.com/v1/pulse/nct-nct07650084-phase3-a-24-week-study-of-the-efficacy-a-1120-1330z","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"b33b27679b6eda78076cc9946056620634e5445efdc5ff7c89bf333f8cb19d3e","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-20T13:30:46.603Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","executive_summary":"Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT07650084, NCT07951593, NCT07950592)","delta_changed_count":6,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT07650084","title":"A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension","status":"TERMINATED","phase":"PHASE3","conditions":"Refractory Chronic Cough","verify_url":"https://clinicaltrials.gov/study/NCT07650084"},{"nct_id":"NCT07951593","title":"Nurse-Led SKIN CARE Bundle on Medical Device-Related Pressure Injuries","status":"COMPLETED","phase":"NA","conditions":"Pressure Ulcer (PU)","verify_url":"https://clinicaltrials.gov/study/NCT07951593"},{"nct_id":"NCT07950592","title":"The ABODE Study for Patients Undergoing Neoadjuvant Chemotherapy","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Breast Cancer and Rehabilitation; Breast Cancer (Early Breast Cancer); Breast Cancer - Female","verify_url":"https://clinicaltrials.gov/study/NCT07950592"},{"nct_id":"NCT06215287","title":"Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Mat","status":"COMPLETED","phase":"OBSERVATIONAL","conditions":"Chronic Iron Overload","verify_url":"https://clinicaltrials.gov/study/NCT06215287"},{"nct_id":"NCT07631871","title":"An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy","status":"RECRUITING","phase":"PHASE2","conditions":"Neoplasms; Solid Tumors; HER2 Positive Solid Tumor","verify_url":"https://clinicaltrials.gov/study/NCT07631871"},{"nct_id":"NCT07075055","title":"Impact of a New Bioceramic Based Intracanal Medication","status":"COMPLETED","phase":"NA","conditions":"Post Operative Pain","verify_url":"https://clinicaltrials.gov/study/NCT07075055"}],"signal_sha256":"b33b27679b6eda78076cc9946056620634e5445efdc5ff7c89bf333f8cb19d3e"}}
clinical-trials.withsilex.com · 2026-11-20 13:30 UTC · Recently updated NIH study NCT07650084 (TERMINATED): A 24-Week Study of the Efficacy and Safety of BLU-5937 in